Therefore, this study addresses a critical knowledge gap by elucidating how these agents modulate the eNOS/BH4/NO axis, Nrf2–ARE pathway, and PI3K–AKT–IRS–GLUT signaling to counteract infection-induced oxidative stress, inflammation, and impaired metabolic signaling in endothelial cells. The gene discussed is NFE2L2; the disease is infection.